Weight loss is never a cakewalk, and for Mia, it was nothing less than unachievable until she found out about Mounjaro weight ...

Patients waiting for NHS weight loss jabs are buying potentially unsafe jabs online or from gyms and beauty salons ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

A lean-looking Elon Musk revealed Wednesday that he uses Mounjaro — after previously expressing support for similar ...

Weight-loss injection Mounjaro, or tirzepatide, will be rolled out on the NHS gradually over a 12-year period, starting this ...

The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a ...

Elon Musk showed off a slender figure on social media while wearing a Santa suit, revealing that he used Mounjaro to achieve ...

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a ...

Tirzepatide, the main ingredient in Mounjaro and Zepbound, is no longer in shortage, according to the U.S. Food and Drug ...

Only 220,000 people will be eligible for Mounjaro under current guidelines - Getty They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and ...

Eli Lilly, a leading US pharmaceutical company, is gearing up to launch its groundbreaking diabetes and obesity medication, Tirzepatide—commercially known as Mounjaro—in India by 2025.